Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment
Xiaoqing Sang, Yuanyuan Wang, Zhifeng Xue, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy
Pengchao Zhao, Xianfeng Xia, Xiayi Xu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 127
Cell-based drug delivery systems and their in vivo fate
Liuxin Yang, Yang Yang, Yang Chen, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114394-114394
Closed Access | Times Cited: 83
Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
Yongjiang Li, Junyong Wu, Xiaohan Qiu, et al.
Bioactive Materials (2022) Vol. 20, pp. 548-560
Open Access | Times Cited: 63
Novel drug delivery systems and disease models for pulmonary fibrosis
Rui Li, Yizhen Jia, Xiaohan Kong, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 95-114
Closed Access | Times Cited: 61
Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
C.Y. Perrot, Τheodoros Karampitsakos, Jose D. Herazo‐Maya
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C1046-C1057
Open Access | Times Cited: 35
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
Zhaokui Jin, Qi Gao, Keke Wu, et al.
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115111-115111
Closed Access | Times Cited: 35
Magnetic liposome as a dual-targeting delivery system for idiopathic pulmonary fibrosis treatment
Xi Wang, Yuying Wang, Zhifeng Xue, et al.
Journal of Colloid and Interface Science (2023) Vol. 636, pp. 388-400
Closed Access | Times Cited: 25
Macrophage-related therapeutic strategies: Regulation of phenotypic switching and construction of drug delivery systems
Xi Wang, Yixuan Li, Xueyu Pu, et al.
Pharmacological Research (2023) Vol. 199, pp. 107022-107022
Open Access | Times Cited: 18
Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems
Sanskriti Singh, Sarika Wairkar
AAPS PharmSciTech (2024) Vol. 25, Iss. 4
Closed Access | Times Cited: 6
Biomaterial-assisted macrophage cell therapy for regenerative medicine
Samuel Sung, Lindsay A. Steele, Gregory E. Risser, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114979-114979
Closed Access | Times Cited: 15
Hyaluronic acid-conjugated liposomes loaded with dexamethasone: A promising approach for the treatment of inflammatory diseases
Kamila Bohne Japiassu, François Fay, Alessandro Marengo, et al.
International Journal of Pharmaceutics (2023) Vol. 639, pp. 122946-122946
Open Access | Times Cited: 12
Advancements in Nanotechnology for Targeted Drug Delivery in Idiopathic Pulmonary Fibrosis: A Focus on Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Suriya Prakaash KK, Damodharan Narayanasamy
Drug Development and Industrial Pharmacy (2025), pp. 1-18
Closed Access
Tryptanthrin alleviate lung fibrosis via suppression of MAPK/NF-κB and TGF-β1/SMAD signaling pathways in vitro and in vivo
Min Niu, Yongzhi Wang, Xianming Deng, et al.
Toxicology and Applied Pharmacology (2025), pp. 117285-117285
Closed Access
Nanodrug Delivery System for Precision Treatment of Pulmonary Fibrosis
Xianhao Yi, Xinru Zhang, Y. Guan, et al.
Precision medicine and engineering. (2025), pp. 100025-100025
Open Access
Caveolin Scaffolding Domain (CSD) Peptide LTI-2355 Modulates the Phagocytic and Synthetic Activity of Lung-Derived Myeloid Cells in Idiopathic Pulmonary Fibrosis (IPF) and Post-Acute Sequelae of COVID Fibrosis (PASC-F)
Brecht Creyns, BreAnne MacKenzie, Yago Amigo Pinho Jannini de Sá, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 796-796
Open Access
Desmoplastic tumor priming using clinical-stage corticosteroid liposomes
Tarun Ojha, Gideon J L Schaefer, Rahaf Mihyar, et al.
(2025), pp. 100051-100051
Open Access
Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis
Ruyi Qu, Mengxian Zhou, Yan Qiu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110392-110392
Closed Access | Times Cited: 10
Synergistic effects of mesenchymal stem cell-derived extracellular vesicles and dexamethasone on macrophage polarization under inflammatory conditions
Zahra Mirsanei, Fatemeh Jamshidi‐Adegani, Saeid Vakilian, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1317-1332
Closed Access | Times Cited: 3
Designing biomaterials for the treatment of autoimmune diseases
Beikang Tang, Xiaoyan Xie, Juan Lu, et al.
Applied Materials Today (2024) Vol. 39, pp. 102278-102278
Closed Access | Times Cited: 2
Single‐cell combined with transcriptome sequencing to explore the molecular mechanism of cell communication in idiopathic pulmonary fibrosis
Minggao Zhu, Yu-Hu Yi, Kui Jiang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 2
Liposomal UHRF1 siRNA shows lung fibrosis treatment potential through regulation of fibroblast activation
Demin Cheng, Yue Wang, Ziwei Li, et al.
JCI Insight (2022) Vol. 7, Iss. 22
Open Access | Times Cited: 10
Identification of circRNA expression profiles and the potential role of hsa_circ_0006916 in silicosis and pulmonary fibrosis
Qiuyun Wu, Biyang Jiao, Qianyi Zhang, et al.
Toxicology (2022) Vol. 483, pp. 153384-153384
Closed Access | Times Cited: 10
Pulmonary Fibrosis: Unveiling the Pathogenesis, Exploring Therapeutic Targets, and Advancements in Drug Delivery Strategies
Kirti Aggarwal, Sandeep Arora, Kalpana Nagpal
AAPS PharmSciTech (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 5
Biomaterial-mediated intracellular control of macrophages for cell therapy in pro-inflammatory and pro-fibrotic conditions
Tina Tylek, Joanna Wong, Andrew E. Vaughan, et al.
Biomaterials (2024) Vol. 308, pp. 122545-122545
Open Access | Times Cited: 1
Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria
Xueyu Pu, Yuanyuan Wang, Xi Wang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2238-2249
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top